Open access
Open access
Powered by Google Translator Translator

Daily Archives: October 26, 2022

ACR/EULAR remission criteria for rheumatoid arthritis: 2022 Revision.

26 Oct, 2022 | 14:39h | UTC

American College of Rheumatology/EULAR Remission Criteria for Rheumatoid Arthritis: 2022 Revision – Arthritis & Rheumatology

Commentary: New ACR/EULAR Guideline Expands RA Remission Definition – MedPage Today (free registration required)

 

ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update.

26 Oct, 2022 | 14:38h | UTC

ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update – Annals of the Rheumatic Diseases

 

Review | Hypercalcemia.

26 Oct, 2022 | 14:37h | UTC

Hypercalcemia: A Review – JAMA (free for a limited period)

Author Interview: Hypercalcemia—A Review – JAMA

 

Multimodality imaging and image guidance techniques for endovascular ascending aortic repair.

26 Oct, 2022 | 14:37h | UTC

Multimodality imaging and image guidance techniques for endovascular ascending aortic repair – JTCVS Techniques

 

Guidelines for best practice in the audiological management of adults using bimodal hearing configurations.

26 Oct, 2022 | 14:35h | UTC

Guidelines for Best Practice in the Audiological Management of Adults Using Bimodal Hearing Configurations – Otology & Neurotology Open

 

Commentary on Twitter

 

Expert Consensus | Imaging standardization in metastatic colorectal cancer.

26 Oct, 2022 | 14:36h | UTC

Imaging standardisation in metastatic colorectal cancer: A joint EORTC-ESOI-ESGAR expert consensus recommendation – European Journal of Cancer

 

Optimizing medication use in older adults with rheumatic diseases: deprescribing as an approach when less may be more.

26 Oct, 2022 | 14:33h | UTC

Optimizing Medication Use in Older Adults With Rheumatic Musculoskeletal Diseases: Deprescribing as an Approach When Less May Be More – ACP Open Rheumatology

Related:

Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy – European Heart Journal – Cardiovascular Pharmacotherapy

Deprescribing in Older Adults with Cardiovascular Disease – Journal of the American College of Cardiology

Multimorbidity in Older Adults with Cardiovascular Disease – American College of Cardiology, Latest in Cardiology

Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis – Health Technology Assessment

Antihypertensive Deprescribing in Older Adults: a Practical Guide – Current Hypertension Reports

How-to guide for medication reviews in older adults with cancer: A Young International Society of Geriatric Oncology and Nursing & Allied Health Interest Group initiative – Journal of Geriatric Oncology

Deprescribing in Palliative Cancer Care – Life

Less is More: Deprescribing Medications in Older Adults with Kidney Disease: A Review – Kidney360

Process evaluation of implementation strategies to reduce potentially inappropriate medication prescribing in older population: A scoping review – Research in Social and Administrative Pharmacy

AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review – Gastroenterology

Development of a Metric to Detect and Decrease Low-Value Prescribing in Older Adults – JAMA Network Open

The MedSafer Study—Electronic Decision Support for Deprescribing in Hospitalized Older Adults: A Cluster Randomized Clinical Trial – JAMA Internal Medicine

Quantifying Anticholinergic Burden and Sedative Load in Older Adults with Polypharmacy: A Systematic Review of Risk Scales and Models – Drugs & Aging

Deprescribing in palliative patients with cancer: a concise review of tools and guidelines – Supportive Care in Cancer

Prescribing practices, patterns, and potential harms in patients receiving palliative care: A systematic scoping review – Exploratory Research in Clinical and Social Pharmacy

A narrative review of evidence to guide deprescribing among older adults – Journal of General and Family Medicine

Polypharmacy, inappropriate prescribing, and deprescribing in older people: through a sex and gender lens – The Lancet Health Longevity

Polypharmacy Management in Older Patients – Mayo Clinic Proceedings

Psychopharmacological Treatment in Older People: Avoiding Drug Interactions and Polypharmacy – Deutsches Ärzteblatt international

Eliminating Medication Overload: A National Action Plan – Lown Institute

International Group for Reducing Inappropriate Medication Use & Polypharmacy (IGRIMUP): Position Statement and 10 Recommendations for Action – Drugs & Aging

Common ED Medication Errors: Polypharmacy – emDocs

Current and future perspectives on the management of polypharmacy – BMC Family Practice

Routine deprescribing of chronic medications to combat polypharmacy – Therapeutic Advances in Drug Safety

Polypharmacy—an Upward Trend with Unpredictable Effects – Deutsches Ärzteblatt international

Clinical Consequences of Polypharmacy in Elderly – Expert Opinion on Drug Safety

 

RCT | Intraoperative electrocorticography using high-frequency oscillations or spikes to tailor epilepsy surgery.

26 Oct, 2022 | 14:34h | UTC

Intraoperative electrocorticography using high-frequency oscillations or spikes to tailor epilepsy surgery in the Netherlands (the HFO trial): a randomised, single-blind, adaptive non-inferiority trial – The Lancet Neurology

 

Review | Smartphone apps in stroke management.

26 Oct, 2022 | 14:31h | UTC

Smartphone App in Stroke Management: A Narrative Updated Review – Journal of Stroke

Commentary: Stroke Management: There’s an App for That – Medscape (free registration required)

 

M-A | Age, sex, race, BMI, and duration of type 2 DM differences in cardiovascular outcomes with glucose lowering drugs.

26 Oct, 2022 | 14:32h | UTC

Age, sex, race, BMI, and duration of diabetes differences in cardiovascular outcomes with glucose lowering drugs in type 2 diabetes: A systematic review and meta-analysis – eClinicalMedicine

Commentary: Meta-analysis may guide optimal type 2 diabetes glucose-lowering agent for MACE protection – medwire News

 

The bleeding cervical cancer patient: systematic approach and management.

26 Oct, 2022 | 14:30h | UTC

The Bleeding Cervical Cancer Patient: Systematic Approach and Management – emDocs

 

M-A of RCT | Sleep deprivation is not effective as a treatment for major depressive episodes.

26 Oct, 2022 | 14:29h | UTC

Sleep deprivation as a treatment for major depressive episodes: A systematic review and meta-analysis – Sleep Medicine Reviews

 

M-A | Non-affective psychotic disorders and risk of dementia.

26 Oct, 2022 | 14:30h | UTC

Non-affective psychotic disorders and risk of dementia: a systematic review and meta-analysis – Psychological Medicine

Commentaries:

People with schizophrenia are 2.5 times more likely to develop dementia – News Medical/University College London

Psychotic Disorders May Raise Risk for Later Dementia – HealthDay

 

Single-arm P2 study | Toxic effects of stereotactic ablative radiotherapy for up to 5 oligometastases in patients with cancer.

26 Oct, 2022 | 14:28h | UTC

Treatment With Stereotactic Ablative Radiotherapy for Up to 5 Oligometastases in Patients With Cancer: Primary Toxic Effect Results of the Nonrandomized Phase 2 SABR-5 Clinical Trial – JAMA Oncology (link to abstract – $ for full-text)

Commentary: Stereotactic Ablative Body Radiotherapy Produces Acceptable Toxic Effects in Patients With Cancer and Oligometastses – Cancer Network

 

Commentary on Twitter

 

New horizons in Type 2 myocardial infarction: pathogenesis, assessment and management of an emerging geriatric disease.

26 Oct, 2022 | 14:27h | UTC

New horizons in Type 2 myocardial infarction: pathogenesis, assessment and management of an emerging geriatric disease – Age and Ageing

 

M-A | Non-pharmacologic and pharmacologic treatments for anxiety in long-term care.

26 Oct, 2022 | 14:26h | UTC

Non-pharmacologic and pharmacologic treatments for anxiety in long-term care: a systematic review and meta-analysis – Age and Ageing

 

Phase 2 RCT | Immunoglobulin has no corticosteroid-sparing effects in Myasthenia Gravis.

26 Oct, 2022 | 14:25h | UTC

A Randomized, Double-Blind, Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis – Neurology

 

Differentiating multiple sclerosis from AQP4-neuromyelitis optica spectrum disorder and MOG-antibody disease with imaging.

26 Oct, 2022 | 14:24h | UTC

Differentiating Multiple Sclerosis From AQP4-Neuromyelitis Optica Spectrum Disorder and MOG-Antibody Disease With Imaging – Neurology (PDF)

 

Commentary on Twitter

 

Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.